Kratom in the News
September 2025Kratom is making headlines again with a new FDA warning for 7-hydroxymitragynin (7-OH), a concentrated kratom constituent that binds to opioid receptors and has abuse potential. While the FDA is specifically targeting 7-OH products, it’s a good opportunity to discuss kratom’s risks with patients.